Tetsuya Tomita

Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction <i>in vivo</i>

Noriyuki Tamai, Akira Myoui, Tetsuya Tomita et al. · Journal of Biomedical Materials Research · 2001 · 411 citations · Full text

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 349 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +14

Angiotensin II accelerates osteoporosis by activating osteoclasts

Hideo Shimizu, Hironori Nakagami, Mariana Kiomy Osako et al. · The FASEB Journal · 2008 · 294 citations

Molecular Pharmacology, Hypertension, Angiotensin Ii +13

Lymphoid Chemokine B Cell-Attracting Chemokine-1 (CXCL13) Is Expressed in Germinal Center of Ectopic Lymphoid Follicles Within the Synovium of Chronic Arthritis Patients

Kenrin Shi, Kenji Hayashida, Motoharu Kaneko et al. · The Journal of Immunology · 2001 · 276 citations

Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor ?B decoy oligodeoxynucleotides as a gene therapy

Tetsuya Tomita, Eiji Takeuchi, Naruya Tomita et al. · Arthritis & Rheumatism · 1999 · 218 citations